Phl p 5a derivatives with reduced allergenicity and retained T-cell reactivity

Details for Australian Patent Application No. 2004245184 (hide)

Owner Merck Patent GmbH

Inventors Kahlert, Helga; Cromwell, Oliver; Weber, Bernhard; Nandy, Andreas; Wald, Martin; Fiebig, Helmut

Agent Davies Collison Cave

Pub. Number AU-B-2004245184

PCT Pub. Number WO2004/108758

Priority 103 25 508.7 04.06.03 DE

Filing date 6 May 2004

Wipo publication date 16 December 2004

Acceptance publication date 24 March 2011

International Classifications

C07K 14/415 (2006.01) Peptides having more than 20 amino acids - from plants

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/108758 Priority application(s): WO2004/108758

24 March 2011 Application Accepted

  Published as AU-B-2004245184

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004245187-Aroyl semicarbazide derivatives against thromboembolic diseases

2004245182-Direct coating method